Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02370446 · ClinicalTrials.gov registry record
Testing a Personalize Medication Log for Patients With Lymphoma
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 5
- Enrollment target
NCT02370446: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02370446 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02370446 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to see if using the MedLog is helpful to patients. Since the investigators do not yet know if this MedLog is helpful, some patients will receive it and some will receive our standard of care. The investigators want to know whether providing patients with this additional information is helpful and if having this additional information about their treatment schedule has an effect on their quality of life.
Interventions
- BEHAVIORAL questionnaires
- OTHER standard of care
- BEHAVIORAL Cognitive Interview
- OTHER personalized medication log
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2015-01 |
| Est. Completion | 2017-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02370446
The ClinicalTrials.gov registry entry for NCT02370446 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which questionnaires is the first listed.
NCT02370446 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02370446 about?
NCT02370446 is a clinical study titled "Testing a Personalize Medication Log for Patients With Lymphoma". The purpose of this study is to see if using the MedLog is helpful to patients. Since the investigators do not yet know if this MedLog is helpful, some patients will receive it and some will receive our standard of care. The investigators want to know whether providing patients with this additional ...
What is the current status of trial NCT02370446?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2015-01. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02370446?
The interventions under investigation include: questionnaires (BEHAVIORAL), standard of care (OTHER), Cognitive Interview (BEHAVIORAL), personalized medication log (OTHER).
Who is sponsoring clinical trial NCT02370446?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.